Research report
Radioimmunoassays for glutamic acid decarboxylase (GAD65) and GAD65 autoantibodies using 35S or 3H recombinant human ligands

https://doi.org/10.1016/0022-1759(95)00139-2Get rights and content

Abstract

Autoantibodies are an important marker of human autoimmune diseases and the development of simple, precise and reproducible immunoassays to detect autoantibodies is important to our understanding of human autoimmunity. GAD65 autoantibodies occur frequently in insulin-dependent diabetic patients and is a useful marker for IDDM. A RIA to detect immunoreactive GAD65 has not been described. In the present study we describe a semi-automated fluid-phase immunoassay for the rapid detection of GAD65 autoantibodies in human serum. We also developed a sensitive RIA to determine immunoreactive human GAD65 in biological fluids and in vitro cell systems. Using in vitro translated recombinant human GAD65 in a multiwell-adapted procedure, our GAD65Ab RIA combines high specificity and sensitivity with a high capacity to analyze a large number of samples. In this report the three critical steps in the GAD65Ab RIA, DNA preparation, in vitro translation and immunoprecipitation, have been optimized. In our RIA, GAD65Ab were detected in 116155 (75%) new onset Swedish IDDM children and in 185 (1.2%) healthy controls. In an immunoassay to detect autoantibodies against the proinsulin converting enzyme 2 (PC-2) no such antibodies were detected in IDDM patients. In the GAD65 RIA the lower detection limit was 2 ng/ml (31 fmol/ml). Our data demonstrate that autoantigen radioligands produced by in vitro translation are useful in RIA for autoantibodies and autoantigens in studies of human autoimmunity.

References (28)

  • A. Falorni et al.

    Radioimmunoassay detects the frequent occurrence of autoantibodies to the Mr 65,000 isoform of glutamic acid decarboxylase in Japanese insulin-dependent diabetes

    Autoimmunity

    (1994)
  • C.J. Greenbaum et al.

    Insulin autoantibodies measured by RIA methodology are more related to IDDM than those measured by ELISA

    J. Clin. Endocrinol. Metab.

    (1992)
  • C.E. Grubin et al.

    The cDNA-directed, in vitro-synthesized nascent peptide of glutamic acid decarboxylase (GAD2) is the autoantigen in insulin-dependent diabetes

    Clin. Res.

    (1992)
  • C.E. Grubin et al.

    A novel radioligand binding assay to determine diagnostic accuracy of isoform-specific glutamic acid decarboxylase antibodies in childhood IDDM

    Diabetologia

    (1994)
  • Cited by (194)

    • Diagnosis and classification of autoimmune hypophysitis

      2014, Autoimmunity Reviews
      Citation Excerpt :

      Interestingly, gamma-enolase is expressed in both the pituitary and the placenta, thus providing a theoretical basis for the strong association between pituitary autoimmunity and pregnancy. The use of radioligand binding assays [62] has led to several studies in organ-specific autoimmune diseases. This technique has shown the presence of autoantibodies against pituitary gland specific factor 1a (PGSF1a) in 33% patients with biopsy-proven LH and in 20% patients with isolated ACTH deficiency [63].

    View all citing articles on Scopus

    Part of this paper was presented in abstract form at the First International Congress of the British Society of Immunology, Brighton, UK, December 1993.

    View full text